Loperamid Dr.Max 2 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

loperamid dr.max 2 mg

dr. max pharma s.r.o., Česká republika - loperamid - 49 - digestiva, adsorbentia, acida

LOPERAMID WZF POLFA Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

loperamid wzf polfa

warszawskie zaklady farmaceutyczne polfa s.a., poľsko - loperamid - 49 - digestiva, adsorbentia, acida

Loperamid Grindeks 2 mg tvrdé kapsuly Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

loperamid grindeks 2 mg tvrdé kapsuly

as grindeks, lotyšsko - loperamid - 49 - digestiva, adsorbentia, acida

Verzenios Európska únia - slovenčina - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - neoplazmy prsníkov - antineoplastické činidlá - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Zokinvy Európska únia - slovenčina - EMA (European Medicines Agency)

zokinvy

eigerbio europe limited - lonafarnib - progeria; laminopathies - iné alimentárny trakt a metabolizmus výrobky, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.

Erlotinib Mylan 150 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

erlotinib mylan 150 mg

mylan ireland limited, Írsko - erlotinib - 44 - cytostatica

Erlotinib Mylan 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

erlotinib mylan 100 mg

mylan ireland limited, Írsko - erlotinib - 44 - cytostatica

Erlotinib STADA 150 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

erlotinib stada 150 mg

stada arzneimittel ag, nemecko - erlotinib - 44 - cytostatica

Erlotinib STADA 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

erlotinib stada 100 mg

stada arzneimittel ag, nemecko - erlotinib - 44 - cytostatica

Erlotinib Sandoz 150 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

erlotinib sandoz 150 mg

sandoz pharmaceuticals d.d., slovinsko - erlotinib - 44 - cytostatica